Mode
Text Size
Log in / Sign up

Probiotics reduce nasal and eye symptom scores in children with allergic rhinitisProbiotics may help children with allergic rhinitis nasal and eye symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider probiotics as a possible adjunct for allergic rhinitis symptoms in children, but interpret results cautiously due to heterogeneity.

This is a systematic review and meta-analysis of randomized trials in children aged under 18 years with allergic rhinitis. The review synthesized evidence on probiotics, prebiotics, or synbiotics versus placebo for nasal symptom scores, eye symptom scores, quality of life, and serum eosinophils.

The meta-analysis found a significant reduction in nasal symptom scores with a standardized mean difference (SMD) of -1.40 (95% CI: -2.26 to -0.54). Eye symptom scores also showed a significant reduction (SMD = -3.59, 95% CI: -5.84 to -1.33). Quality of life improved significantly (SMD = -2.98, 95% CI: -4.85 to -1.12). Serum eosinophils showed a small but significant increase (SMD = 0.29, 95% CI: 0.06 to 0.52).

The authors acknowledge substantial heterogeneity across studies as a key limitation. Safety data, including adverse events and discontinuations, were not reported. The certainty of evidence is limited by this heterogeneity.

Practice relevance suggests a potential adjunctive role for probiotics, but findings should be interpreted with caution. Further high-quality, standardized trials are needed to confirm effects and clarify immunological markers.

This systematic review and meta-analysis looked at how probiotics, prebiotics, and synbiotics affect children under 18 years old with allergic rhinitis. The researchers combined data from 1,739 children across multiple studies to see if these supplements helped with symptoms. They compared the supplements against a placebo, which is an inactive treatment used as a control.

The analysis showed a significant reduction in nasal symptom scores and eye symptom scores for children taking the supplements. Quality of life also improved significantly in the group receiving these interventions. These results suggest that these supplements might help manage the day-to-day discomfort associated with allergic rhinitis.

However, the study has important limitations. There was substantial heterogeneity, meaning the studies were very different from one another, which makes the overall picture less clear. Additionally, the supplements showed no consistent beneficial effects on immunological markers like serum eosinophils. Because of these differences and the nature of the data, the findings should be interpreted with caution. Further high-quality, standardized trials are needed to confirm these results before they can change medical practice.

What this means for you:
Probiotics may reduce nasal and eye symptoms in children with allergic rhinitis, but more research is needed.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Allergic rhinitis (AR) is a prevalent chronic inflammatory disorder in children, often undiagnosed and associated with reduced quality of life and risk of comorbidities such as asthma. Probiotics have been found to be potential modulators of immune responses in allergic conditions. This systematic review and meta-analysis evaluated the efficacy of probiotics compared with placebo in the management of pediatric AR. METHODS: Searches were conducted in accordance with a pre-registered protocol using MEDLINE (PubMed), the Web of Science, Scopus, and Embase through April 8, 2025. Randomized controlled trials (RCTs) of children aged < 18 years that compared probiotics, prebiotics, or synbiotics with a placebo were considered for inclusion. Outcomes of interest included clinical and laboratory parameters. Random-effects models with Hedges' g were used; heterogeneity was assessed via I. RESULTS: Fourteen RCTs involving 1,739 children were included. Meta-analysis revealed a significant reduction in nasal symptom scores (SMD = -1.40; 95% CI: -2.26 to -0.54; I = 91.3%) and eye symptom scores (SMD = -3.59; 95% CI: -5.84 to -1.33; I = 94.3%). Quality of life (RQLQ) was also significantly improved (SMD = -2.98; 95% CI: -4.85 to -1.12; I = 95.7%). Among laboratory markers, a small but significant increase in serum eosinophils was observed (SMD = 0.29; 95% CI: 0.06 to 0.52; I = 0%). CONCLUSION: Probiotics were associated with improvements in nasal and ocular symptoms and quality of life in children with AR; however, these findings should be interpreted with caution due to substantial heterogeneity across studies. Probiotics may have a potential role as an adjunctive therapy, but further high-quality, standardized trials are needed. PROSPERO registration code: CRD420250654461 on 24 February 2025. What is Known • Probiotics have been investigated as adjunctive therapy for pediatric allergic rhinitis because of their potential immunomodulatory effects. • Previous studies and meta-analyses have reported inconsistent findings regarding the clinical and immunological effects of probiotics in allergic rhinitis. What is New •This meta-analysis demonstrated significant improvements in nasal symptoms, ocular symptoms, and quality of life in children with allergic rhinitis receiving probiotics versus placebo. • Probiotic supplementation showed no consistent beneficial effects on immunological markers, while substantial heterogeneity remained across studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.